EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Impact of Antibacterials on the Quality of Anticoagulation Control in Patients Initiating Warfarin Therapy

Kyohei Sugiyama, Keita Hirai, Masato Tsutsumi, Shota Furuya, Kunihiko Itoh

American Journal of Cardiovascular Drugs · 2025

DOI: 10.1007/s40256-024-00690-0 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift American Journal of Cardiovascular Drugs, 2025. Verfasst von Kyohei Sugiyama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Genetics, University of Shizuoka, 52-1 Yada Suruga-ku, Shizuoka, 422-8526, Japan. Hauptthemen laut MEDLINE: Warfarin, Anticoagulants, Anti-Bacterial Agents, Blood Coagulation. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Warfarin interacts with antibacterials to prolong the prothrombin time international normalized ratio (PT-INR) and increase the risk of bleeding. Patients initiating warfarin therapy often undergo precise dosage adjustments; however, the clinical implications of these interactions with antibacterials remain unclear. This study aimed to clarify the effect of antibacterials on PT-INR during the warfarin induction phase. METHODS: This was a retrospective, observational study. Patients who were newly treated with warfarin after cardiovascular surgery were included. The primary endpoint was the comparison of the maximum PT-INR and time in therapeutic range (TTR) after warfarin initiation between the antibacterial-treated (ABx) and non-treated (non-ABx) groups. RESULTS: The maximum PT-INR was significantly higher in the ABx group (which included β-lactams, glycopeptides, quinolones, tetracyclines, and aminoglycosides) than in the non-ABx group (median [interquartile range] 2.37 [2.03-2.71] vs. 2.08 [1.93-2.33]; P = 0.005); however, the TTR did not differ significantly (65% [44-76] vs. 71% [43-85]; P = 0.150). The odds ratio for maximum PT-INR > 2.6 with antimicrobial therapy was 2.51 (95% confidence interval 1.21-5.21). DISCUSSION: Antibacterial therapy was a risk factor for a maximum PT-INR >2.6. However, there was no association with the TTR, which is a marker of good outcomes. This was due to the strict warfarin dosing regimen according to the algorithm, which immediately and appropriately adjusted for PT-INR overexpansion. CONCLUSIONS: Antibacterials have been suggested to increase PT-INR during the induction phase of warfarin. However, with strict dose adjustments, the clinical impact on the PT-INR and TTR is likely limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WarfarinAnticoagulantsAnti-Bacterial AgentsBlood CoagulationHumansRetrospective StudiesMaleInternational Normalized RatioFemaleAgedMiddle AgedHemorrhageDrug InteractionsProthrombin Time

Substanzen

WarfarinAnticoagulantsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Genetics, University of Shizuoka, 52-1 Yada Suruga-ku, Shizuoka, 422-8526, Japan.
  • Department of Pharmacy, Shizuoka General Hospital, 4-27-1 Kita Ando Aoi-ku, Shizuoka, 420-8527, Japan.
  • Department of Clinical Pharmacology and Therapeutics, Shinshu University Graduate School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan. hiraik@shinshu-u.ac.jp.
  • Department of Pharmacy, Shinshu University Hospital, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan. hiraik@shinshu-u.ac.jp.
  • Department of Clinical Pharmacology and Genetics, University of Shizuoka, 52-1 Yada Suruga-ku, Shizuoka, 422-8526, Japan. itohk@u-shizuoka-ken.ac.jp.

Zitieren

APA

Sugiyama, K., Hirai, K., Tsutsumi, M., Furuya, S., & Itoh, K. (2025). Impact of Antibacterials on the Quality of Anticoagulation Control in Patients Initiating Warfarin Therapy. American Journal of Cardiovascular Drugs. https://doi.org/10.1007/s40256-024-00690-0

Vancouver

Sugiyama K, Hirai K, Tsutsumi M, Furuya S, Itoh K. Impact of Antibacterials on the Quality of Anticoagulation Control in Patients Initiating Warfarin Therapy. American Journal of Cardiovascular Drugs. 2025. doi:10.1007/s40256-024-00690-0

BibTeX
@article{Sugiyama2025,
  author = {Sugiyama, Kyohei and Hirai, Keita and Tsutsumi, Masato and Furuya, Shota and Itoh, Kunihiko},
  title = {Impact of Antibacterials on the Quality of Anticoagulation Control in Patients Initiating Warfarin Therapy},
  journal = {American Journal of Cardiovascular Drugs},
  year = {2025},
  doi = {10.1007/s40256-024-00690-0}
}
Kostenlos starten →